US2004053854A1PendingUtilityA1
Process for preparation of 4,5-Epoxymorphinan-6-oxyglucuronides
Est. expiryMay 13, 2018(expired)· nominal 20-yr term from priority
A61P 25/04C07H 17/08
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Conjugation of 4,5-Epoxymorphinan-6-ols with Bromoglucuronides in the presence of Zinc containing compounds as activator under conditions capable of forming 4,5-Epoxymorphinan-6-oxyglucuronides is disclosed. This novel approach provides an efficient method for preparation of both anomers of 4,5-Epoxymorphinan-6-oxyglucuronides. The deprotected end products are useful as analgesic agents.
Claims
exact text as granted — not AI-modified1 . A process for the synthesis of a protected 4,5-Epoxymorphinan-6-oxyglucuronide of formula [1] or a salt or complex thereof
wherein:
position 7 and 8 are olefin as shown or dihydro adduct;
R 1 is alkyl, hialoalkyl, arylmnethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, lialoalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl,
R 2 is alkyl, haloalkyl or aralkyl;
R 3 is alkyl, arylmethyl, allyl, cyclopropylmethyl, cyclobutylmethyl, hydrogen, acyl, alkoxycarbonyl, aralkoxycarbonyl, halo alko xycarbonyl , vinyl oxycarbonyl or all yl oxycarbonyl ;
R 4 is alkyl, haloalkyl, arylmethyl, 2(4-morpholinyl)ethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl.
comprising reaction of a Bromoglucuronide of the formula [2]
wherein
R 1 and R 2 are as previously defined;
with a 4,5-Epoxymoiphinan-6-ols of the formula [3] or a salt or complex thereof
wherein
R 3 and R 4 are as previously defined;
in the presence of a Zinc containing compound under conditions capable of forming said protected 4,5-Epoxymoiphinan-6-oxyglucuronide [1] or a salt or complex thereof.
2 . A process according to claim 1 wherein said 4,5-Epoxymorphinan-6-ol is selected from the compounds of the formula [3a]
wherein
R 4 is as previously defined.
3 . A process according to claim 1 wherein said 4,5-Epoxymorphinan-6-ol is selected from 3-O-Acylmorphine, 3-O-Acylnormorphine, 3-O-Acylnalbuphine, 3-O-Acylnalorphine, 3-O-Acyldihydromorphine, 3-O-Benzylmorphine, 3-O-Benzyldihydromorphine, N,O 3 -Dibenzylnormorphine, Codeine, Ethylmorphine, Dihydrocodeine, Pholcodine, 3-O-Alkoxycarbonylmorphine, 3-O-Benzyloxycarbonylmorphine, N,O 3 -Bis(benzyl oxycarbonyl)normorphine.
4 . A process according to claim 1 wherein said Bromoglucuronide is selected from compounds of formula [2a]
wherein
R is acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl; R 2 is as previously defined.
5 . A process according to claim 1 wherein said Bromoglucuronide is selected from compounds of formula [2b]
wherein
R is as previously defined.
6 . A process as recited in claim 1 wherein said protected 4,5-Epoxymorphinan-6-oxyglucuronide is an N-Methyl-4,5-epoxymorphinan-6-oxyglucuronide of formula [1a] or derivative.
wherein:
position 7 and 8 can be olefin as shown or dihydro adduct;
R is acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl, allyloxycarbonyl, benzyoxylcarbonyl, nitrobenzyloxycarbonyl, methoxybenzylcarbonyl or aroxycarbonyl R2 is alkyl, haloalkyl or aralkyl;
R 4 is alkil, haloalkyl, arylmethyl, 2-(4-morpholinyl)ethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl.
7 . A process as recited in claim 1 wherein R 2 and R 3 are methyl.
8 . A process according to claim 1 wherein said protected 4,5-epoxymorphinan-6-oxyglucuronide is of formula [1b].
wherein
R and R 4 are as previously defined.
9 . A process as recited in claim 1 wherein the said reaction occurs in the presence of molecular sieves.
10 . A process as recited in claim 1 wherein the reaction occurs in a non-protic reaction inert solvent.
11 . A process as recited in claim 10 wherein the inert solvent is selected from Chloroform, Dichloromethane or Dichloroethane.
12 . A process as recited in claim 1 wherein the Zinc containing compound is Zinc Bromide.
13 . Use of a Zinc complex of a general formula [3b]
wherein
R 3 and R 4 are as previously defined;
X is a halogen or a cyano-group;
n 0.5÷2
for preparation of a protected 4,5-Epoxymorphinan-6-oxyglucuronide of a general formula [1] or a salt or complex thereof
wherein
R 1 , R 2 , R 3 and R 4 are as previously defined.
14 . A process for the synthesis of a protected 4,5-Epoxymorphinan-6-oxyglucuronide of formula [1] or a salt or complex thereof
wherein:
position 7 and 8 are olefin as shown or dihydro adduct; R 1 is alkyl, haloalkyl, arylmethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl;
R 2 is alkyl, haloalkyl or aralkyl;
R 3 is alkyl, arylmethyl, allyl, cyclopropylmethyl, cyclobutylmethyl, hydrogen, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl;
R 4 is alkyl, haloalkyl, arylmethyl, 2-(4-morpholinyl)ethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl
comprising reaction of Bromoglucuronide of the formula [2]
wherein
R 1 and R 2 are as previously defined;
with complex of the formula [3b] under conditions capable of forming said protected 4,5-Epoxymorphinan-6-oxyglucuronide [1] or a salt or complex thereof.
15 . A compound having the following formula:
wherein:
position 7 and 8 is olefin as shown or dihydro adduct;
R 2 and R 3 are as previously defined;
R 6 is selected from alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl, allyloxycarbonyl and R 5 is selected from alkyl, haloalkyl, arylmethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl, allyloxycarbonyl or R 6 is selected from alkyl, haloalkyl, arylmethyl, 2-(4-morpholinyl)ethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl, allyloxycarbonyl when one of R 5 is selected from alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl, allyloxycarbonyl.
16 . A compound having the following formula:
wherein:
position 7 and 8 is olefin as shown or dihydro adduct;
R 7 is hydrogen, alkyl, haloalkyl, arylmethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl;
R 8 is hydrogen, alkyl, haloalkyl or aralkyl;
R 9 is hydrogen, alkyl, arylmethyl, allyl, cyclopropylmethyl, cyclobutylmethyl, hydrogen, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl;
R 10 is hydrogen, alkyl, haloalkyl, arylmethyl, 2-(4-morpholinyl)ethyl, acyl, alkoxycarbonyl, aralkoxycarbonyl, haloalkoxycarbonyl, vinyloxycarbonyl or allyloxycarbonyl.
17 . A compound of formula [1c] according to claim 15 wherein R 2 and R 3 are both Me.
18 . A protected 4,5-Epoxymorphinan-6-oxyglucuronide synthesised according to any of claims 1 to 12 or 14 .
19 . A process for synthesising M6G comprising: synthesising a protected 4,5-Epoxymorphinan-6-oxyglucuronide according to any of claims 1 to 12 or 14 ; and hydrolysing the protected 4,5-Epoxymorphinan-6-oxyglucuronide to form M6G.
20 . M6G synthesised according to claim 19 .
21 . M6G synthesised using a zinc complex according to claim 13.Join the waitlist — get patent alerts
Track US2004053854A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.